SHAIRAH CARPIO: Open Payments
NPI 1043809254 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,940 in 113 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,940
Food & beverage: $2,841Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $572 |
| Madrigal Pharmaceuticals | 19 | $545 |
| Janssen Biotech, Inc. | 12 | $364 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $212 |
| Phathom Pharmaceuticals, Inc. | 8 | $177 |
| Celltrion USA Inc. | 7 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $154 |
| Regeneron Healthcare Solutions, Inc. | 4 | $119 |
| Boston Scientific Corporation | 1 | $114 |
| Gilead Sciences, Inc. | 4 | $107 |
Products named: REZDIFFRA, TREMFYA, XIFAXAN, LINZESS, DUPIXENT, VOQUEZNA, VEGZELMA, CREON.
Industry payments across CA — which companies pay providers there.
